• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表达墨西哥利什曼原虫主要表面蛋白gp63的伤寒沙门氏菌CVD 908候选疫苗株的免疫原性。

Immunogenicity of a Salmonella typhi CVD 908 candidate vaccine strain expressing the major surface protein gp63 of Leishmania mexicana mexicana.

作者信息

González C R, Noriega F R, Huerta S, Santiago A, Vega M, Paniagua J, Ortiz-Navarrete V, Isibasi A, Levine M M

机构信息

Unidad de Investigación Médica en Inmunoquímica, México, D.F., México.

出版信息

Vaccine. 1998 May-Jun;16(9-10):1043-52. doi: 10.1016/s0264-410x(97)00267-3.

DOI:10.1016/s0264-410x(97)00267-3
PMID:9682357
Abstract

Attenuated Salmonella typhi are attractive for use as live vector vaccines to express protozoal antigens and deliver them to the human immune system. The gene encoding the mature form of Leishmania mexicana mexicana gp63 under control of tac promoter was integrated into the delta aroC locus of the chromosome of attenuated delta aroC, delta aroD S. typhi strain CVD 908. After oral immunization of BALB/c mice with two 1 x 10(9) colony forming unit doses given 21 days apart, CVD 908 omega (delta aroC::Ptac-gp63) elicited a broad T cell-mediated immune response against L. m. mexicana gp63 as demonstrated by: (1) lymphoproliferative response to fixed whole L. m. mexicana promastigotes; (2) activation of IL-2 (but not IL-4)-producing lymphocytes; (3) appearance of cytotoxic T cells against mouse mastocytoma cells expressing gp63. This T-cell mediated immune response was associated with significant protection in F1 (BALB/cXC57Bl/6) mice challenged in their footpads with a wild type strain of L. m. mexicana.

摘要

减毒伤寒沙门氏菌作为活载体疫苗来表达原生动物抗原并将其递送至人体免疫系统很有吸引力。在tac启动子控制下,编码墨西哥利什曼原虫成熟形式gp63的基因被整合到减毒的aroC缺失、aroD缺失伤寒沙门氏菌菌株CVD 908染色体的aroC缺失位点。在用两个间隔21天的1×10⁹菌落形成单位剂量对BALB/c小鼠进行口服免疫后,CVD 908ω(aroC缺失::Ptac-gp63)引发了针对墨西哥利什曼原虫gp63的广泛T细胞介导的免疫反应,表现为:(1)对固定的完整墨西哥利什曼原虫前鞭毛体的淋巴细胞增殖反应;(2)产生IL-2(而非IL-4)的淋巴细胞的激活;(3)出现针对表达gp63的小鼠肥大细胞瘤细胞的细胞毒性T细胞。这种T细胞介导的免疫反应与在用墨西哥利什曼原虫野生型菌株攻击其足垫的F1(BALB/c×C57Bl/6)小鼠中显著的保护作用相关。

相似文献

1
Immunogenicity of a Salmonella typhi CVD 908 candidate vaccine strain expressing the major surface protein gp63 of Leishmania mexicana mexicana.表达墨西哥利什曼原虫主要表面蛋白gp63的伤寒沙门氏菌CVD 908候选疫苗株的免疫原性。
Vaccine. 1998 May-Jun;16(9-10):1043-52. doi: 10.1016/s0264-410x(97)00267-3.
2
Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63.用表达利什曼原虫表面蛋白酶gp63的重组卡介苗对皮肤利什曼病进行有效免疫接种。
Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11473-7. doi: 10.1073/pnas.90.24.11473.
3
Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis.用糖蛋白63 cDNA进行基因免疫可在利什曼病小鼠模型中引发1型辅助性T细胞免疫反应并提供保护。
Hum Gene Ther. 1998 Sep 1;9(13):1899-907. doi: 10.1089/hum.1998.9.13-1899.
4
Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis.用由T细胞抗原硫醇特异性抗氧化剂、硕大利什曼原虫应激诱导蛋白1和利什曼原虫延伸起始因子组成的多蛋白疫苗进行免疫接种可预防利什曼病。
Infect Immun. 2002 Aug;70(8):4215-25. doi: 10.1128/IAI.70.8.4215-4225.2002.
5
CTL responses to Leishmania mexicana gp63-cDNA vaccine in a murine model.在小鼠模型中针对墨西哥利什曼原虫gp63 - cDNA疫苗的细胞毒性T淋巴细胞反应
Parasite Immunol. 2009 Jul;31(7):373-83. doi: 10.1111/j.1365-3024.2009.01111.x.
6
Comparative study of DNA vaccines encoding various antigens against Leishmania mexicana.编码针对墨西哥利什曼原虫的各种抗原的DNA疫苗的比较研究。
Dev Biol (Basel). 2000;104:135-41.
7
Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans.表达恶性疟原虫环子孢子蛋白的伤寒沙门氏菌疫苗株CVD 908:菌株构建及其在人体中的安全性和免疫原性
J Infect Dis. 1994 Apr;169(4):927-31. doi: 10.1093/infdis/169.4.927.
8
Protection of C57BL/10 mice by vaccination with association of purified proteins from Leishmania (Leishmania) amazonensis.用来自亚马逊利什曼原虫(利什曼原虫)的纯化蛋白联合疫苗接种对C57BL/10小鼠进行保护。
Rev Inst Med Trop Sao Paulo. 1999 Jul-Aug;41(4):243-8. doi: 10.1590/s0036-46651999000400008.
9
Protection against Leishmania major infection in genetically susceptible BALB/c mice by gp63 delivered orally in attenuated Salmonella typhimurium (AroA- AroD-).通过口服减毒鼠伤寒沙门氏菌(AroA - AroD -)递送的gp63对基因易感的BALB/c小鼠进行利什曼原虫主要感染的保护。
Immunology. 1995 May;85(1):1-7.
10
Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response.墨西哥利什曼原虫半胱氨酸蛋白酶缺陷型突变体对小鼠的毒力减弱,并增强Th1反应。
J Immunol. 1998 Dec 15;161(12):6794-801.

引用本文的文献

1
Vaccination in Leishmaniasis: A Review Article.《利什曼病疫苗接种:综述文章》。
Iran Biomed J. 2022 Jan 1;26(1):1-35. doi: 10.52547/ibj.26.1.35.
2
Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis.利什曼病疫苗及其开发对美国皮肤利什曼病的影响。
Hum Vaccin Immunother. 2020 Apr 2;16(4):919-930. doi: 10.1080/21645515.2019.1678998. Epub 2019 Nov 11.
3
Cutaneous Leishmaniasis: Update on Vaccine Development.皮肤利什曼病:疫苗研发进展
Hum Parasit Dis (Auckl). 2017;9. doi: 10.4137/HPD.S16588.
4
Not All Antigens Are Created Equally: Progress, Challenges, and Lessons Associated with Developing a Vaccine for Leishmaniasis.并非所有抗原都是生来平等的:开发利什曼病疫苗的进展、挑战与经验教训
Clin Vaccine Immunol. 2017 Jul 5;24(7). doi: 10.1128/CVI.00108-17. Print 2017 Jul.
5
Immunoinformatics Features Linked to Leishmania Vaccine Development: Data Integration of Experimental and In Silico Studies.与利什曼原虫疫苗开发相关的免疫信息学特征:实验研究与计算机模拟研究的数据整合
Int J Mol Sci. 2017 Feb 10;18(2):371. doi: 10.3390/ijms18020371.
6
Cryptosporidium hominis gene catalog: a resource for the selection of novel Cryptosporidium vaccine candidates.人隐孢子虫基因目录:一种用于筛选新型隐孢子虫疫苗候选物的资源。
Database (Oxford). 2016 Oct 19;2016. doi: 10.1093/database/baw137. Print 2016.
7
Live vaccination tactics: possible approaches for controlling visceral leishmaniasis.活疫苗接种策略:控制内脏利什曼病的可能方法。
Front Immunol. 2014 Mar 31;5:134. doi: 10.3389/fimmu.2014.00134. eCollection 2014.
8
Type IVB pilus operon promoter controlling expression of the severe acute respiratory syndrome-associated coronavirus nucleocapsid gene in Salmonella enterica Serovar Typhi elicits full immune response by intranasal vaccination.IVB型菌毛操纵子启动子控制伤寒沙门氏菌中严重急性呼吸综合征相关冠状病毒核衣壳基因的表达,通过鼻内接种引发完全免疫反应。
Clin Vaccine Immunol. 2007 Aug;14(8):990-7. doi: 10.1128/CVI.00076-07. Epub 2007 Jun 27.
9
Two Salmonella OmpC K(b)-restricted epitopes for CD8+-T-cell recognition.两个用于CD8⁺ T细胞识别的鼠伤寒沙门氏菌OmpC K(b)限制性表位。
Infect Immun. 2004 May;72(5):3059-62. doi: 10.1128/IAI.72.5.3059-3062.2004.
10
Salmonella enterica serovar Typhi live vector vaccines delivered intranasally elicit regional and systemic specific CD8+ major histocompatibility class I-restricted cytotoxic T lymphocytes.经鼻内接种的肠炎沙门氏菌伤寒血清型活载体疫苗可引发局部和全身特异性的、受主要组织相容性复合体I类分子限制的CD8+细胞毒性T淋巴细胞。
Infect Immun. 2002 Aug;70(8):4009-18. doi: 10.1128/IAI.70.8.4009-4018.2002.